 Abstract cannabidiol, CBD, a major non-psychoactive fighter cannabinoid in cannabis, has been shown to be an effective treatment for certain types of epilepsy and pain. New research suggests that CBD interacts with NAV 1.7 channels at low concentrations, stabilizing the channels in activated state and reducing its sensitivity to voltage changes. This interaction could potentially lead to more effective treatments for conditions such as epilepsy and chronic pain.